Loading...
Chemical structure of NHWD-870

GC62620

NHWD-870

Also known as 5-(3,5-dimethyltriazol-4-yl)-12-methyl-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12,13-tetrazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2(7),3,5,10,13,15-heptaene

NHWD-870 is a potent, orally active and selective BET family bromodomain inhibitor and only binds bromodomains of BRD2, BRD3, BRD4 (IC50=2·7 nM), and BRDT· NHWD-870 has potent tumor suppressive efficacies and suppresses cancer cell-macrophage interaction· NHWD-870 increases tumor apoptosis and inhibits tumor proliferation

ChemicalCAS2115742-03-3MW491.59FormulaC29H29N7O
CAS number
2115742-03-3
Molecular weight
491.59
Formula
C29H29N7O
Solubility
DMSO : 125 mg/mL (254·28 mM; Need ultrasonic)
InChIKey
YMSCCGUMGIFOSI-GDLZYMKVSA-N
Catalogue number
GC62620
Brand
GLPBIO
Computed properties PubChem CID 137448679 · XLogP 4.1 · TPSA 75.6 Ų · H-bond donors 0
XLogP
4.1
TPSA
75.6 Ų
H-bond donors
0
H-bond acceptors
5
Rotatable bonds
4
Heavy atoms
37

SMILES CC1=C(N(N=N1)C)C2=CC3=C(C4=C(N3[C@@H](C5CCOCC5)C6=CC=CC=C6)C=C7C(=C4)C=NN7C)N=C2

Computed descriptors from PubChem (CID 137448679), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.